Cargando…
COVID-19 and Sickle Cell Disease: Two Independent Risk Factors for Venous Thromboembolism
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widely documented as a multi-systemic illness and associated with an increased incidence of thromboses. Likewise, sickle cell disease (SCD) is a hematologic disease responsible for w...
Autores principales: | Saxena, Parima, Muthu, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163976/ https://www.ncbi.nlm.nih.gov/pubmed/37159776 http://dx.doi.org/10.7759/cureus.37226 |
Ejemplares similares
-
Risk of venous thromboembolism in a Swedish healthcare system during the COVID‐19 pandemic: A retrospective cross‐sectional study
por: Wretborn, Jens, et al.
Publicado: (2021) -
Sickle Cell Disease and COVID-19 Infection: Importance of COVID-19 Testing and Approach to Management
por: Umar, Zaryab, et al.
Publicado: (2022) -
Lessons Learned From a Case of Behcet’s Disease Presenting With Fever and Life-Threatening Venous Thromboembolism
por: Conlon, Peter, et al.
Publicado: (2022) -
Effect of Anticoagulants in Pulmonary Thromboembolism in Post-COVID-19 Patients
por: Çınar, Caner, et al.
Publicado: (2023) -
The Impact of Clostridium Difficile Infections on In-Hospital Outcomes of Venous Thromboembolism (Deep Vein Thrombosis or Pulmonary Embolism) Hospitalizations
por: Jhaveri, Khushali, et al.
Publicado: (2020)